Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Total Liabilities ₹880 Cr₹793 Cr₹739 Cr₹157 Cr₹119 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹880 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr
Mar2012₹119 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr
32.15
Mar2012 ₹119 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹286.3 Cr -6.4% -10.1% -25% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,592.2 Cr -9.5% -21.2% -0.4% Stock Analytics
KAVERI SEED COMPANY ₹5,148.0 Cr 2.1% 11% 55.9% Stock Analytics
VENKYS (INDIA) ₹2,301.8 Cr -1.3% -9.9% -9.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,405.4 Cr -7% -12.6% -38.5% Stock Analytics
INDO US BIOTECH ₹394.8 Cr -9.8% -10.3% -14.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-6.4%

-10.1%

-25%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses